How Novartis got ahead on ‘incredible’ cancer breakthrough

All NewsSeptember 2, 2025

Swiss pharma group has become a pioneer in radioligand therapy, a new type of targeted radiotherapy

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent